A phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX04 to reference bevacizumab sourced from the United States, the European Union, and China i...

por Zhu, Xiaoxue, Qian, Hongjie, Sun, Jixuan, Wu, Min, Yu, Chen, Ding, Yanhua, Zhang, Xiaodi, Chai, Katherine, Li, Xiaojiao
Publicado 2021

A phase I study comparing the pharmacokinetics and safety of HS628 (tocilizumab biosimilar) and reference tocilizumab in healthy male subjects

por Qian, Hongjie, Cheng, Jie, Gui, Yuzhou, Wang, Wei, Liang, Liyu, Zhu, Huijuan, Wu, Qingqing, Ou, Meixian, Chen, Qian, Yu, Chen, Jia, Jingying
Publicado 2023

Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects

por Qian, Hongjie, Yu, Chengyin, Zhu, Huijuan, Ding, Qichen, Cai, Yuting, Jing, Jiao, Xu, Xin, Guo, Runcong, Zhang, Haiyan, Liu, Hong, Chen, Xiaoyan, Liu, Yun
Publicado 2023

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects

por Qian, Hongjie, Chen, Qian, Liang, Liyu, Zou, Yang, Pu, Huahua, Xin, Liang, Song, Rong, Li, Tingting, Zhu, Huijuan, Wang, Yu, Tian, Guanghui, Shen, Jingshan, Jiang, Hualiang, Yu, Chen, Wang, Zhen, Jia, Jingying
Publicado 2021